Concepedia

Ilaria Portarena

IP

Statistics

Publications

38

Citations

1.6K

H-Index

26

Active since

2000

Affiliations

University of Rome Tor Vergata(Current)

Istituti di Ricovero e Cura a Carattere Scientifico

Policlinico Tor Vergata

Vita-Salute San Raffaele University

Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele

Ilaria Portarena is an author at University of Rome Tor Vergata specializing in medicine, cancer research, and pathology.

Top concepts

Publications per year

2000–2021

38

Publications

38

Systemic administration of GPI 15427, a novel poly(ADP-ribose) polymerase-1 inhibitor, increases the antitumor activity of temozolomide against intracranial melanoma, glioma, lymphoma.

Lucio Tentori, Carlo Leonetti, Marco Scarsella et al. · PubMed · 2003 · 204 citations

New insights into the metastatic behavior after breast cancer surgery, according to well-established clinicopathological variables and molecular subtypes

Oreste Claudio Buonomo, Emanuele Caredda, Ilaria Portarena et al. · PLoS ONE · 2017 · 106 citations · Full text

, , +16

Review. TNF/VEGF cross-talk in chronic inflammation-related cancer initiation and progression: an early target in anticancer therapeutic strategy.

Fiorella Guadagni, Patrizia Ferroni, Raffaele Palmirotta et al. · PubMed · 2007 · 83 citations

, , +20

Combined treatment with temozolomide and poly(ADP-ribose) polymerase inhibitor enhances survival of mice bearing hematologic malignancy at the central nervous system site

Lucio Tentori, Carlo Leonetti, Marco Scarsella et al. · Blood · 2002 · 82 citations · Full text

CRH Inhibits Cell Growth of Human Endometrial Adenocarcinoma Cells via CRH-Receptor 1-Mediated Activation of cAMP-PKA Pathway

Grazia Graziani, Lucio Tentori, Ilaria Portarena et al. · Endocrinology · 2002 · 69 citations · Full text

1–5 of 38